Pharmaceutical Inspection Machines Market Set to Reach USD 1.4 Billion by 2029, Growing at a CAGR of 7.6%
Browse in-depth TOC on “Pharmaceutical Inspection Machines Market“
465 – Tables
51 – Figures
438 – Pages
Market Segmentation by Component
The market is categorized by component into inspection systems and software. The inspection systems segment includes vision inspection systems, X-ray inspection systems, leak detection systems, metal detectors, combination systems, checkweighers, and other types of inspection systems. In 2023, inspection systems held the largest market share and are expected to maintain this dominance through 2029, thanks to advancements in machine vision and AI, alongside the rising production of biologics, biosimilars, and pharmaceutical outsourcing.
Market Segmentation by Type
By type, the market is divided into fully automated inspection systems, semi-automated systems, and manual systems. The fully automated segment was the leading category in 2023, primarily due to higher throughput rates, improved inspection accuracy, increased detection capabilities, and compliance with strict regulatory standards.
Market Segmentation by Packaging Type
Regarding packaging types, the pharmaceutical inspection machines market is segmented into ampoules & vials, syringes, blister packaging, bottles, and other packaging formats. The ampoules & vials segment dominated in 2023 and is projected to see substantial growth during the forecast period, driven by a greater implementation of inspection machinery for these containers. Additionally, the rising demand for vaccines, biopharmaceuticals, and biologics is fueling production in this area.
Market Segmentation by Formulation
In terms of formulation, the market is categorized into oral, parenteral, and other formulations. The oral segment includes tablets & capsules, oral solutions, suspensions/syrups, and other types. The parenteral formulation segment led the market in 2023 and is expected to grow significantly, driven by increasing demand for injectable drugs and the growth of the pharmaceutical and biotechnology sectors.
Market Segmentation by End User
By end user, the market is segmented into pharmaceutical companies, biotechnology companies, and CROs & CDMOs. The pharmaceutical companies segment was the largest in 2023 and is anticipated to grow at a significant CAGR during the forecast period, reflecting the rising use of inspection machines for quality assurance and the urgent need to address counterfeit pharmaceuticals.
Regional Analysis
Geographically, the global pharmaceutical inspection machines market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2023, North America led the market due to factors such as advanced healthcare infrastructure, stringent regulatory requirements (including FDA regulations), significant investment in pharmaceutical R&D, and the presence of major pharmaceutical firms. The Asia Pacific region is expected to experience the highest CAGR from 2024 to 2029, supported by favorable government policies, growing contract manufacturing, increased production of generic drugs, and the rapid expansion of pharmaceutical and biotechnology companies.
Key Players in the Market
Key players in the pharmaceutical inspection machines market include Körber AG (Germany), Mettler-Toledo (Switzerland), Omron Corporation (Japan), Cognex Corporation (US), Stevanato Group (Italy), and Antares Vision S.P.A (Italy), among others. These companies are pursuing both organic and inorganic growth strategies, such as product launches and acquisitions, to maintain their leadership positions in the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=81453085
Körber AG: Market Leader
Körber AG (Germany) leads the pharmaceutical inspection machines market through strategic partnerships, continuous innovation, and significant R&D investments. The company focuses on collaborations to increase its market share. For example, in December 2023, Körber AG partnered with Franz Ziel GmbH (Germany) to enhance its expertise in cleanroom technology for the pharmaceutical and biotech industries. This partnership complements Körber’s existing inspection and packaging solutions. Additionally, Körber’s commitment to R&D and its extensive service network ensure exceptional customer support, solidifying its leading position in the market.
Mettler-Toledo: Innovative Leader
Mettler-Toledo (Switzerland) is a prominent player in the pharmaceutical inspection machines market, known for its innovative product launches. In September 2022, the company introduced high-quality X-ray technology, including the DXD and DXD+ dual energy detector, to identify difficult-to-detect foreign contaminants. Mettler-Toledo also prioritizes strong customer relationships through extensive training and support programs, ensuring optimal product utilization, which reinforces its leadership in the market.
Omron Corporation: Diverse Portfolio
Omron Corporation (Japan) ranks among the top players in the pharmaceutical inspection machines market as of 2023. The company has a diverse portfolio that spans industrial automation, electronic components, automotive parts, social infrastructure systems, healthcare, and environmental solutions. Omron’s strength lies in its advanced inspection machines that ensure product quality and safety. The company invests in developing innovative sensors, robotics, and AI to enhance inspection accuracy and efficiency. With a robust global distribution network and extensive service capabilities, Omron provides excellent customer support and rapid response times.
For more information, inquire now! Inquire Now
Related Reports:
Pharmaceutical Packaging Equipment Market
Pharmaceutical Excipients Market
Active Pharmaceutical Ingredient Market
Get access to the latest updates on Pharmaceutical Inspection Machine Companiesand Pharmaceutical Inspection Machines Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
SOURCE MarketsandMarkets
